Organization
Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
3 abstracts
Abstract
The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.Org: Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany, Department of Women's Health, University of Tübingen, Tübingen, Germany, Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany, Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany,
Abstract
Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.Org: Skin Cancer Center, University Hospital Leipzig, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, Personalis, Inc.,
Abstract
A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.Org: Centre for Cancer Biomarkers CCBIO, University of Bergen, Dept. of Urology, Haukeland University Hospital, Dept. of Pathology,